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device may offer some advantages with respect to seal between
the endograft and chimney grafts. This study aimed to investigate
the feasibility and efﬁcacy of the Nellix Endovascular Aneurysm
Sealing (EVAS) system in conjunction with chimney grafts.
A prospective evaluation of patients treated for juxtarenal and
suprarenal non-ruptured aortic aneurysms using the Nellix system
and chimney grafts was undertaken in a single Vascular Unit in the
United Kingdom.
Between February 2013 and April 2015 28 patients were
treated with EVAS in a chimney graft conﬁguration. Mean age was
74 years (8 years) and mean aneurysm size 67 mm (10 mm).
Eight patients underwent suprarenal aneurysm repair including a
chimney graft in the superior mesenteric artery. Five patients had
a double chimney conﬁguration; all the other patients were
treated with a single chimney conﬁguration. There was one 30-day
or in-hospital mortality (3.6%) due to Multi-Organ Failure (MOF)
after repair of a symptomatic aneurysm; three other patients died
within one year, due to pancreatic cancer (diagnosed after sur-
gery), pneumonia, and sepsis respectively. One patient experi-
enced a transient ischemic attack (TIA), followed by a full recovery
and two patients suffered from a minor stroke (7%). No patient
required postoperative renal replacement therapy.
The chimney technique, in combination with endovascular
aneurysm sealing, appears to offer an effective solution for jux-
tarenal and suprarenal aneurysms with adverse morphology in the
short-term.
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Three-dimensional (3D) fusion computed tomography (CT) is a
new technology that may reduce radiation in FEVAR (fenestrated
endovascular aneurysm repair). The aim of this study was to
evaluate the radiation dose effect of introducing fusion imaging to
an expert team.
Procedural details were gathered prospectively 18 consecutive
patients receiving fusion-guided (Fusion Group) FEVAR and
compared with 21 patients treated in the 12 months prior to the
implementation of routine fusion imaging (Standard Group). Pro-
cedure time (PT), radiation dose, dose-area product (DAP), ﬂuo-
roscopy time (FT), estimated blood loss (EBL) and pre- and post-
operative estimated glomerular ﬁltration rate (eGFR) were
compared between groups.
The Fusion group (n ¼ 18) received three 2 vessel-, ten 3 vessel-
, four 4 vessel-, and one single vessel-fenestrated graft(s). The
Standard group (n ¼ 21) received ﬁve 4 vessel-, eleven 3 vessel-,
four 2 vessel-, and one single-vessel graft(s). There was a signiﬁ-
cant reduction in PT for the Fusion group (median 285 mins;
interquartile range 265e323) compared with the Standard group
(420 mins; IQR 330e310 p ¼ <0.001). There were signiﬁcant re-
ductions in radiation skin dose for the Fusion group (1.65 Gy;
1.22e2.22) compared with the Standard group (4.39 Gy; 3.28e
7.05 p ¼ <0.001), and DAP; Fusion (173.64 Gy cm2; 138.33e
232.77) vs (264.93 Gy cm2; 173.37e366.85) for Standard
(p ¼ 0.001). EBL was reduced for Fusion (350 mls; 250e560)compared with Standard (1000 mls; 420e2300 p ¼ 0.01). There
was no difference in FT.
Implementation of fusion imaging signiﬁcantly reduces radia-
tion dose and other performance measures, and improves the
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Endovascular aneurysm sealing (EVAS) is a potential alternative to
endovascular aneurysm repair (EVAR) in patients with infrarenal
abdominal aortic aneurysms (AAA). The early clinical experience,
technical reﬁnements, and learning curve of EVAS in the treatment
of AAA at a single institution are presented.
105 patients were treated with EVAS between March 2013 and
November 2014. Prospective data were recorded on consecutive
patients receiving EVAS, including demographics aneurysm
morphology, and 30-day outcomes, including rates of endoleak,
limb occlusion, reintervention, and death. Postoperative imaging
consisted of duplex ultrasound and computed tomographic
angiography.
Mean age was 76  8 years and 12% were female. Adverse neck
morphology was present in 72 (69%) patients, including aneurysm
neck length <10 mm (20%), neck diameter >32 mm (18%), b-
angulation >60 (21%), and conical aneurysm neck (51%). One
death and four Type 1 endoleaks (4%) occurred within 30 days. All
four proximal endoleaks were associated with technical issues that
resulted in procedure reﬁnement, and all were in patients with
adverse proximal aortic necks. Following treatment with trans-
catheter embolization, the persistent Type 1 endoleak rate at 30
days was 0%. There were no Type 2 or Type 3 endoleaks. Angio-
plasty and adjunctive stenting were performed for postoperative
limb stenosis in three patients (3%).
EVAS is associated with reasonable 30-day outcomes, with
applicability to patients with challenging aortic morphology.
Endoleak rates should reduce with procedural experience. The
utility of EVAS will be deﬁned its durability in long-term follow-up,
although the absence of Type 2 endoleaks is encouraging.A 19-year Experience of Secondary Interventions Following EVAR
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EVAR is increasingly used as the primary mode of treatment for
aneurysmal disease. However, this technique is associated with
complications that mandate life-long follow up. We present a 19-
year single-centre experience with EVAR, speciﬁcally examining the
indications for re-intervention and the methods used.
A retrospective analysis was conducted of all EVAR cases per-
formed at the Freeman Hospital from 1995e2014.
In a 19-year period 1100 standard EVARs were performed (947
abdominal; 161 thoracic). There were a total of 303 re-in-
terventions in 212 patients (19%). Indications for re-intervention
included: Endoleak (n ¼ 180; 16%); sac expansion without endo-
leak (n ¼ 38; 14%); limb occlusion (n ¼ 40; 0.03%); disease pro-
gression (n ¼ 28; 0.03%) and rupture (n ¼ 10; 0.9%).
e18 AbstractsThere were 214 endovascular interventions (71%) for endoleak
and disease progression. 89 open interventions were required
(29%). Almost half of open interventions were for limb ischaemia
or groin complications. Open conversion was required for the
majority of ruptures (n ¼ 8/10) and continued sac expansion
without endoleak (n ¼ 33). The mortality associated with open
conversion was 10%.
This series represents one of the largest in the literature and
has a re-intervention rate of 19%, in line with previous reports.
Although re-intervention is common, most complications can be
successfully treated with endovascular techniques. However, if
open abdominal intervention is required, there is a high mortality
and the authors therefore propose a ‘stent conserving’ approach
to open intervention.Repair of Thoraco-abdominal and Peri-renal Aneurysms with the
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The multi-layer ﬂow modulating stent (MFMS) is a novel approach
for the treatment of complex aortic aneurysms. We report out-
comes in a UK pilot study of treatment of aortic arch, thoraco-
abdominal (TAAA) and perirenal aneurysms (PAA).
With MHRA Devices Agency and ethical approval, patients who
were unﬁt for open surgery and had no option for complex endo-
vascular repair were recruited. Follow-up included CTA at one,
three, six and 12 months, then annually for three years. Outcome
measures included 30 daymortality, rupture, branch vessel patency,
complications, re-intervention and maximal aortic diameter.
Fourteen patients (6 PAA, 6 TAAA, 2 arch) were treated be-
tween October 2011 and March 2014; mean follow up is 19.4
months. Seven patients (50%) have died including one fatal
rupture. 30 day mortality was 7.14%. 12 month survival was
78.6%. In those alive at 12 months, four remained stable while
aneurysm size had increased by >5 mm in seven. To date, three of
the seven surviving patients have remained stable on the most
recent available imaging. 50 of 51 covered aortic branches
remained patent with no embolic stroke or visceral ischaemia. Sixre-interventions were performed in ﬁve patients (35%). There was
one post re-intervention death.
The early MFMS devices have had little inﬂuence on the natural
history of complex aortic aneurysms. Side branch patency was
maintained but these MFMS frequently dislocated. Further
development is needed if this novel technology is to have a role in
treating aortic aneurysm.
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The effect of thoracic endovascular aortic repair (TEVR) on the
aneurysm sac remains undeﬁned. The aim of this study was to
characterize the incidence of aneurysm sac expansion rate after
TEVR and the effect of aortic morphology on sac behaviour.
A database of patients with pre and post-operative computed
tomography angiogram (CTA) was provided by M2S, Inc. (2004 to
2013). All patients underwent TEVR for thoracic aortic aneurysms.
Preoperative aortic anatomy including diameters, lengths and
angulations were available for each patient. Post-TEVR sac
expansion was deﬁned as a >5 mm increase between the pre-
operative and follow up CTA. The inﬂuence of pertinent aortic
morphology on sac expansion was assessed using Kaplan-Meier
analysis.
Of 899 patients undergoing TEVR, 46% had a maximum aneu-
rysm diameter above the 55-mm threshold. The 5-year freedom
from sac expansion was 61%. Several preoperative morphological
factors were found to be associated with signiﬁcant sac expansion
after TEVR. The length of the proximal sealing zone <20 mm
(p ¼ 0.020), distal sealing zone <30 mm (p ¼ 0.008), proximal and
distal neck diameters over 38 mm (both, p < 0.001), distal aortic
arch angle <60 (p ¼ 0.049) and a maximal preoperative sac
diameter >50 mm (p ¼ 0.003) were more likely to be associated
with sac expansion after 5 years.
This observational study demonstrated that post-TEVR aneu-
rysm sac expansion is higher than expected, and this appears to
be signiﬁcantly inﬂuenced by several preoperative morphological
factors. Meticulous preoperative patient selection and proce-
dural planning is required to ensure favourable long-term
results.
